Withers & Rogers

Dr Nicholas Jones and Elizabeth Swan, patent attorneys at European intellectual firm Withers & Rogers, explain why pharma companies may be missing out on opportunities to repurpose existing drugs. Read more

, Opinion

Partner and patent attorney at intellectual property firm, Withers & Rogers, Dr Nicholas Jones, discusses why drug companies should continue to pursue new medical patents in the future, despite recent examples of legal disputes. Read more